DJIA 17,598.20 -91.66 -0.52%
NASDAQ 5,115.38 -12.90 -0.25%
S&P 500 2,098.04 -5.80 -0.28%
market minute promo

Biogen Idec (NASDAQ: BIIB)

324.38 5.60 (1.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BIIB $324.38 1.76%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $320.33
Previous Close $318.78
Daily Range $319.11 - $325.81
52-Week Range $290.85 - $480.18
Market Cap $76.3B
P/E Ratio 21.52
Dividend (Yield) $0.00 (0.0%)
Volume 3,024,371
Average Daily Volume 2,607,242
Current FY EPS $15.93




Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website:

News & Commentary

This Latest Study Adds 1 More Piece to the Alzheimer's Puzzle

Alzheimer's is a terrifying, costly, and mysterious disease that attacks a patient's cognition. However, a new study sheds light on what could be one of its greatest risk factors.

Will Isis Pharmaceuticals (ISIS) Beat Q2 Earnings Estimates? - Analyst Blog

Drugs Stocks On The Rise With Help From 3 Stocks

A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch

Insider Weekends - July 31, 2015

Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'

Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More

The Blockbuster Potential of Biogen Inc's Pipeline

Blue chip biotech stock Biogen has a strong pipeline full of drugs that could offer multi billion dollar opportunity. Lets take a closer look at the potential.

Acorda 2Q Earnings & Revenues Top, Ampyra in Focus - Analyst Blog

Earnings Season: The Good, The Bad, And The Ugly. And Why I Remain A Bull

See More BIIB News...

BIIB's Top Competitors

BIIB $324.38 (1.76%)
Current stock: BIIB
AMGN $175.59 (-0.57%)
Current stock: AMGN
GILD $119.60 (1.48%)
Current stock: GILD
$0.00 (0.00%)
Current stock: